Literature DB >> 24788871

Motility and trafficking in B-cell non-Hodgkin's lymphoma (Review).

Kathleen J Till1, Sarah E Coupland1, Andrew R Pettitt1.   

Abstract

B cell non-Hodgkin's lymphomas (B-NHLs) consist of a wide spectrum of entities and consequently have varied clinical courses. Like many other malignancies, each of the B-NHL depend on their microenvironment for growth and survival; therefore, understanding the factors involved in their tissue localisation is likely to have implications for therapies designed to treat B-NHL. This review summarises the chemokines, integrins and sphingosine-1 phosphate receptors involved in normal B cell location and distribution within the lymphoid tissues (lymph nodes, spleen and bone marrow). It also provides a précis of what is known about these factors in the disease state: i.e., in some subtypes of B-NHL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788871     DOI: 10.3892/ijo.2014.2395

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Inhibitory effect of Embelin on human acute T cell lymphoma Jurkat cells through activation of the apoptotic pathway.

Authors:  Xiu-Li Zhu; Lian Jiang; Fan Qu; Zhi-Yu Wang; Lian-Mei Zhao
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

2.  HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins.

Authors:  Xiaoyu Jiang; XiaoQing Lu; Andrew J Gentles; Dekuang Zhao; Seth A Wander; Yu Zhang; Yasodha Natkunam; Joyce Slingerland; Isildinha M Reis; Brian Rabinovich; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2021-12-14

3.  BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.

Authors:  Zsuzsa Nagy-Baló; Richárd Kiss; Judit Demeter; Csaba Bödör; Zsuzsa Bajtay; Anna Erdei
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

4.  Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.

Authors:  Kathleen J Till; Andrew R Pettitt; Joseph R Slupsky
Journal:  J Immunol       Date:  2015-01-28       Impact factor: 5.422

Review 5.  Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.

Authors:  Lutz Menzel; Uta E Höpken; Armin Rehm
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

6.  Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer.

Authors:  Chiara Facciotto; Julia Casado; Laura Turunen; Suvi-Katri Leivonen; Manuela Tumiati; Ville Rantanen; Liisa Kauppi; Rainer Lehtonen; Sirpa Leppä; Krister Wennerberg; Sampsa Hautaniemi
Journal:  Clin Epigenetics       Date:  2019-12-11       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.